Pancreas Adenocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-12-27
Clinical Trial Update: A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating a PD-1 inhibitor with or without a vitamin D analog for maintenance therapy in pancreatic cancer has completed enro…